MAPT participants who participated in the extended observational follow‐up were younger, had better cognitive performance, a lower CAIDE dementia risk score, a higher level of education, and were less likely to be diabetic or to be APOE ε4 carriers, than those who did not, but the participation rate did not differ by randomization group (Table S1 in supporting information). This evidence concerns the gene APOE and dementia.